Roth Capital Has Negative Outlook for CELZ FY2028 Earnings
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Free Report) – Equities research analysts at Roth Capital lowered their FY2028 earnings estimates for shares of Creative Medical Technology in a research report issued to clients and investors on Wednesday, February 12th. Roth Capital analyst J. Aschoff now forecasts that the company will earn $6.02 per share […]
